Clinical Trial Update: Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating navtemadlin with radiation therapy for soft tissue sarcoma; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Resectable Soft Tissue Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Navtemadlin (navtemadlin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED | Results posted: 2024-11-08